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Abstract 
In recent years accumulating evidence supports the importance of microRNAs in liver 
physiology and disease; however few studies have examined the involvement of these 
non-coding genes in chemical hepatocarcinogenesis. Here we examined the liver 
microRNA profile of male Fischer rats exposed through their diet to genotoxic (2-
acetylaminofluorene) and epigenetic (phenobarbital, diethylhexylphthalate, 
methapyrilene HCL, monuron, chlorendic acid) chemical hepatocarcinogens, as well 
as to non-hepatocarcinogenic treatments (benzophenone; diethythiourea) for three 
months. The effects of these treatments on liver pathology, plasma clinical 
parameters, and liver mRNAs were also determined. All hepatocarcinogens affected 
the expression of liver mRNAs, while the hepatic microRNA profiles were associated 
with the mode of action of the chemical treatments and corresponded to chemical 
carcinogenicity. The three nuclear receptor activating chemicals (phenobarbital, 
benzophenone, and diethylhexylphthalate) were characterized by the highly 
correlated induction of the miR-200a/200b/429, which is involved in protecting the 
epithelial status of cells, and of the miR-96/182 clusters. The four non-nuclear 
receptor activating hepatocarcinogens were characterized by the early, persistent 
induction of miR-34, which was associated with DNA-damage and oxidative stress in 
vivo and in vitro. Repression of this microRNA in a hepatoma cell line led to 
increased cell growth, thus miR-34a could act to block abnormal cell proliferation in 
cells exposed to DNA-damage or oxidative stress. This study supports the proposal 
that hepatic microRNA profiles could assist in the earlier evaluation and 
identification of hepatocarcinogens, especially those acting by epigenetic 
mechanisms.    
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Introduction 
The liver is a frequent target for toxicity induced by exogenous chemicals, due to the 
metabolizing activities of hepatocytes and the high concentrations of orally ingested 
chemicals passing to it directly from the gastrointestinal tract (Hardisty & Brix, 
2005). Exogenous chemicals can drive carcinogenesis by a variety of mechanisms 
(Irigaray & Belpomme, 2010; Hernandez et al., 2009). DNA-damaging chemicals 
drive carcinogenesis by causing detrimental mutations of cancer genes. Conversely, 
non-DNA reactive chemicals do not damage DNA, but rather drive carcinogenesis by 
more subtle, epigenetic mechanisms (Boobis et al.,2009), including the  induction of 
oxidative stress, of cycles of necrosis/regeneration, or by disrupting physiological 
mitosis and/or apoptosis (Irigaray & Belpomme, 2010; Hernandez et al., 2009). 
Oxidative stress can damage DNA and proteins through the generated free radicals, as 
well as disturbing cellular signalling. Cytotoxic chemicals cause cycles of 
necrosis/regeneration, which promote the growth of neoplastic lesions, the eventual 
depletion of telomeres, and the release of pro-inflammatory chemokines and 
cytokines. Disruption of the normal proliferation and apoptosis balance drives tumor 
promotion by favoring the expansion of mutated cells. 
To protect human health, novel chemicals are evaluated for potential carcinogenicity. 
DNA-reactive chemicals can be readily and reliably detected by a number of in vitro 
and in vivo tests, such as mutation, chromosomal aberration, and micronucleus assays 
(Boobis et al., 2009). In contrast, no reliable assays exist for the identification of 
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human epigenetic carcinogens. This situation arises due to the limited understanding 
of the molecular, biochemical, and cellular events that are associated with epigenetic 
carcinogenesis. Consequently, risk assessment for carcinogenicity of chemicals (the 
rodent bioassay) is currently a laborious, complicated, time-consuming, animal 
demanding, and costly process (Boobis et al., 2009). Moreover, this current 
benchmark for the evaluation of novel chemicals is often irrelevant to humans due to 
species differences and the high doses which are used (Boobis et al., 2009). The 
development of better assays for epigenetic hepatocarcinogens is dependent on an 
improved understanding of the molecular events associated with this type of 
chemical. 
MicroRNAs (miRNAs) are a family of evolutionary conserved non-coding RNAs that 
post-transcriptionally regulate their target genes. In recent years accumulating 
evidence supports the importance of liver microRNAs in physiology and disease, 
including cancer (Bala et al., 2009). Numerous studies have shown altered expression 
in liver tumors (e.g. Hou et al., 2011; Pineau et al., 2010); However, so far only a 
handful of studies have examined the function of miRNAs during chemical 
hepatocarcinogenesis and these have been mostly restricted to a single chemical 
treatment (Li et al., 2010; Malik et al., 2011; Moffat et al., 2007; Pogribny et al. 
2009; Shah et al., 2007; Yauk et al., 2010). In this study the effects of sub-chronic 
treatment with a variety of chemical treatments were examined in parallel. Chemical 
treatments were chosen to represent diverse modes of action (MOA), carcinogenic 
potential, and effects on the liver. For each chemical its maximum tolerated dose or a 
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carcinogenic dose, as reported in the literature, for this rat strain were used. PB and 
BP belong to the PB-type class of compounds that activate the constitutive androstane 
receptor (CAR) (Chhbra, 2000; Kodama and Negishi, 2006), while DEHP activates 
the peroxisome proliferator-activated receptor alpha (pparα) (Lapinskas et al. 2005). 
Chronic activation of these receptors drives hepatocarcinogenesis in rodents by 
disrupting proliferation/apoptosis of initiated cells (Lake, 2010). All three chemicals 
cause the induction of hepatic tumors in mice, but only PB and DEHP have the same 
effect in this rat strain (Butler, 1978; NTP TR-217; NTP TR-533).  MP HCl is an 
hepatotoxic hepatocarcinogen that promotes cancer by inducing necrosis/regeneration 
(Lijinsky, 1984). The potent hepatocarcinogen 2-AAF was the only genotoxic 
chemical used here, while also having additional promoting faculties (Neuman et al. 
1997). Also included in this study were two non-DNA damaging hepatocarcinogens 
with unknown MOA, MON (NTP TR-266) and Chl Ac (NTP TR-304). As a control 
chemical DETU was included, a kidney carcinogen with few reported liver effects 
(NTP TR-149). We found that assessing the hepatic miRNAome is a potentially 
useful avenue for assessing the mechanisms and carcinogenic potential of chemical 
treatments. 
Materials and methods 
Animal study 
All the chemicals used in this study were purchased from Sigma-Aldrich (Dorset, 
United Kingdom). Male Fischer (F344) rats were obtained from Harlan Olac 
(Netherlands) and left to acclimatise for seven days prior to commencement of the 
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treatments. Animals were then randomly assigned to cages and treatment. The 
chemical treatments used in this study are summarised in Table 1. Nine-week old rats 
were continually exposed to each chemical in their diet (N=5 animals per group) for a 
period of up to three months. The animal studies were performed in accordance with 
the UK “Animals (Scientific procedures) Act” under controlled lighting (12h light 
cycles), humidity (30-70%), air flow (15 changes per hour), and temperature (22±3 
C) conditions. Rats were given access to mains water and diet ad libitum. Exposure of 
the animals to the chemicals was verified by chemical analysis of the diets and daily 
monitoring of food intake. At the end of the study, animals were killed by an 
overdose of anaesthetic (halothane Ph.Eur.Vapour) followed by exsanguination. Liver 
tissue was obtained from the animals immediately upon sacrifice, snap frozen, and 
stored at -80C until needed. 
Evaluation of histopathology and measurement of clinical parameters 
For histopathology liver sections were taken from the three main liver lobes, 
embedded in paraffin wax, sectioned at 5µm, stained with haematoxylin and eosin, 
and examined by light microscopy. For clinical chemistry plasma was collected and 
the levels of glutamate dehydrogenase, alanine aminotransferase, and aspartate 
aminotransferase were measured.  
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mRNA Microarray analysis 
Profiling of liver mRNAs was performed as previously described (Waterman et al., 
2010), using the Affymetrix Rat Expression RG-230 v2 GeneChips (Affymetrix, 
Buckinghamshire, United Kingdom).  
miRNA microarray analysis 
For miRNA analysis total RNA was extracted from the left lateral liver lobes using 
Trizol (Invitrogen, Paisley, United Kingdom) following the manufacturer’s 
instructions. The RNA was deemed suitable for microarray analysis if it had a 
260:280 ratio above 2.0 (as determined by Nanodrop ND-1000) and a RIN number 
larger than eight (as determined using an Agilent Bioanalyser). For miRNA profiling 
three to five liver samples from each group were examined. Profiling of miRNA 
expression was performed using the Agilent miRNA microarray platform (Agilent, 
Stockport, United Kingdom). The microarray slides contained the 350 rat miRNAs 
that were included in the Sanger 10.1 database. The slides were viewed using an 
Agilent scanner (G2505B) and the data were collected using the Agilent Feature 
Extraction v.10.1 software. The miRNA hybridisation signals were threshold to 1, 
log2 transformed, and normalised to the 75th percentile in Genespring GX 11.0. 
MiRNAs that were not flagged as present by the Agilent feature extraction software 
in at least 50% of the samples in any treatment group were filtered out from further 
analysis. For six liver samples (three control animals and three PB treated animals) 
the whole process from RNA extraction onwards was performed twice to assess the 
Page 7 of 43 Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
8 
 
reproducibility of the generated microarray data (Control and PB technical 
replicates). 
Quantitative Real Time PCR (qPCR) analysis  
For mRNAs reverse transcription was performed using the High capacity cDNA RT 
kit (Applied Biosystems, Warrington, United Kingdom). The generated cDNA was 
amplified using the Taqman 2X Universal PCR master mix, No AmpErase UNG 
(Applied Biosystems), with each PCR reaction performed in triplicate. The qPCR 
data were analysed in the ABI 7500 Sequence Detection System (Applied 
Biosystems). The comparative Ct Method (∆∆CT Method) was used to quantify 
miRNA expression. Calibration was based on the expression of the 18s rRNA 
Taqman. For miRNAs total RNA was reverse transcribed using the TaqMan 
MicroRNA Reverse Transcription Kit (Applied Biosystems). Mature miRNA taqman 
assays were purchased from Applied biosystems. Quantification was performed as 
per manufacturer’s instructions using 18s rRNA or snoRNA as the calibrator gene. 
Cell culture 
Fao rat hepatoma cells (ECACC 85061112) were maintained in DMEM media 
supplemented with 10% FBS. Recombinant human tgf-beta1 was purchased from R 
& D (Abingdon, United Kingdom) and used as described previously (Caja et 
al.,2007). Etoposide and hydrogen peroxide were obtained from Sigma-Aldrich.  
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Statistical Analysis  
Student’s t-test and ANOVA were used to test for statistical significance. Deregulated 
mRNAs were identified as those with p<0.05 (t-test from control) and more than 1.5-
fold change from control. Over-expressed gene ontology categories were identified as 
those with p<0.01 within Genespring GX 11.0. One-way ANOVA with Benjamini 
Hochberg multiple testing correction followed by Tukey HSD post hoc test were used 
to identify differentially expressed miRNAs. To identify predictive miRNA 
signatures the Prediction Analysis of Microarrays (PAM) software was used 
(Tibshrani et al., 2002). 
Results 
Effects of chemical treatments on liver pathology, clinical chemistry, and mRNA 
profiles 
To certify that the treatments had the expected hepatic effects we evaluated plasma 
clinical parameters, liver pathology and biochemistry, and liver mRNA expression of 
the treated animals (Tables 2-3). The nuclear receptor activators (PB, BP and DEHP) 
resulted in hepatic hypertrophy and significant increases in adjusted liver weight 
(Table 2). PB and BP treatments also induced cyp2b1 (11.5-fold and 9.5-fold from 
control respectively), which is a defining characteristic of CAR activation (Lake, 
2010). Similarly, DEHP caused changes in the expression of mRNAs that are 
characteristic of pparα activation, such as the induction of cyp4a1 (4.7-fold from 
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control) and an enrichment of genes involved in lipid metabolism (Lake, 2010; 
Lapinskas et al., 2005) (Table 3).  
In accordance with its known cytotoxic properties MP HCL caused the largest 
increases in the plasma levels of three markers of hepatotoxicity (glutamate 
dehydrogenase, aspartate aminotransferase, and alkaline aminotransferase) (Table 2); 
was the only compound for which evidence of necrosis/apoptosis was found upon 
histopathological examination (Table 2); and together with 2-AAF were the only 
treatments that resulted in an enrichment of the cell cycle Gene Ontology (GO) group 
affecting a number of cell cycle genes (Tables 3-4). 2-AAF was also the only 
compound to cause an enrichment of the programmed cell death GO group (Table 3 
and Table 5), although no increase in liver necrosis/apoptosis was detected (Table 
2).  
MON was the only compound besides the nuclear receptor activators to induce a 
significant, albeit small, increase in adjusted liver weight at three months (113% 
control), as well as to induce minimal liver vacuolation (Table 2). Both MON and 
Chl. Ac caused an enrichment of mRNAs involved in the oxidation-reduction GO, 
while Chl. Ac also affected a number of genes involved in lipid metabolism (Table 
3). The non-hepatocarcinogen DETU had few effects on the examined liver 
parameters (Tables 2), affected fewer mRNAs (Table 3), and did not result in the 
enrichment of any GO group (Table 3). Overall, chemical treatments had the 
expected hepatic effects after subchronic treatment (Chhbra, 2000; Lake, 2010; 
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Lapinskas et al., 2005; Neuman et al., 1997; NTP-TR-149; NTP-TR-266; NTP-TR-
304).  
Effects of chemical treatments on the liver miRNAome at three months 
We next used a microarray platform to examine the effects of the chemical treatments 
on the liver miRNAome. Box plot analysis demonstrated comparable distributions of 
the microarray samples (Fig. 1A), while two sets of technical replicates revealed a 
very strong correlation of miRNA expressions (Fig.1B), confirming the reliability and 
reproducibility of the microarray data. As independent validation the expression 
levels of five miRNAs were determined by qPCR and found to be highly correlated to 
their expression changes calculated by microarrays (Fig. 1C). Therefore, the 
microarray platform that was utilized here proved to be reliable and reproducible.  
With one way ANOVA and Bonferonni-Holm multiple testing correction, 21 
miRNAs had significantly altered expression in animals treated with one or more 
compounds compared to control animals after three months (Table 6). Importantly, 
all the hepatocarcinogens had effects on the liver miRNAome, while no hepatic 
miRNAs displayed significant deregulation compared to control following treatment 
with the non-hepatocarcinogen chemical DETU. The deregulated miRNAs included 
several belonging to the same genomic clusters or families, which as expected 
showed highly correlated expression in response to the chemical treatments 
(Pearson’s correlations for miR-200b-miR-200a r=0.98; miR-200b-miR-429 r=0.96; 
miR-96-miR-182 r=0.96; miR-99a-miR-100 r=0.98; miR-29a-miR-29c r=0.95). 
Importantly, the clustering of the samples based on the differentially expressed 
Page 11 of 43 Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
12 
 
miRNAs follows a logical order, suggesting that hepatic miRNA profiles reflect the 
mode of action of the chemicals (Fig.1D). DETU, the chemical with the least effects 
on the liver, associated with the control animals. In a second node the two PB-type 
compounds, PB and BP, clustered together. A third node contained the two 
compounds which had the largest effect on cell cycle at three months (MP HCL and 
2-AAF). Hepatic miRNA profiles also clustered together the three most potent 
hepatocarcinogens tested in this study (2-AAF, MP HCL, and Chl.Ac). 
It should be noted that the chemical treatments caused both downregulation and 
upregulation of miRNAs (Table 6). In terms of magnitude, most altered miRNAs 
were changed between 1.5 to 5-fold from control, similar to the changes observed 
between HCC and benign liver tissue (Hou et al., 2008). Some of the observed 
miRNA deregulation was specific to a particular compound, for example the 
induction of miR-107 by DEHP or miR-139-5p by Chl. Ac. We were particularly 
interested in identifying miRNAs that were affected by more than one chemical, as 
these could be involved in a more general adaptive or adverse response to the 
treatment. Compared to control animals, ten miRNAs had significantly altered 
expression in the livers of animals treated with two or more chemicals: members of 
the miR-200a/200b/429 cluster (PB, DEHP, BP, 2-AAF, Chl.Ac, and MP HCL) ; 
members of the miR-96/182 cluster (PB, DEHP, BP, MON); miR-34a (2-AAF, MP 
HCL, Chl.Ac, MON), miR-99a (2-AAF, MP HCL, MON), miR-203 (2-AAF and 
Chl.Ac), miR-193 (MON and Chl.Ac), and miR-221 (BP and DEHP). Of these 
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miRNAs only miR-221 was deregulated in a different direction by treatments, being 
induced by DEHP and repressed by BP.  
It was also observed that there was a significant correlation between the number of 
mRNA probes and miRNAs that were deregulated compared to control for each 
treatment (r=0.74; p<0.05 Spearman’s correlation) indicating that there is an 
association between strength of the perturbation induced by chemical treatments on 
these two gene classes.  
In conclusion, our findings demonstrate that chemical hepatocarcinogens affect liver 
miRNA profiles after long term treatments, that these profiles are associated with the 
MOA of chemicals, and that a surprisingly consistent set of miRNAs are affected by 
chemical treatments.  
Effect of nuclear receptor activators on liver miRNAs 
The three nuclear receptor activators (PB, BP, and DEHP) had clearly distinct effects 
on liver pathology, including the induction of hepatomegaly and hypertrophy (Table 
2). At the miRNA level the characteristic common response elicited by these 
compounds was a highly positively correlated induction of the miR-200a/200b/429 
and of the miR-96/182 clusters (r=0.99, p<0.001 Pearson’s correlation between miR-
96 and miR-200b in CON, PB, BP, and DEHP treated samples), something which 
was not observed for the other compounds (Fig.2A-2B). 
The two PB-type compounds (PB and BP) are both reported to be mice 
hepatocarcinogens, but only PB is reported to be hepatocarcinogenic in male Fischer 
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rats (Butler et al.1978; NTP TR-533). The two compounds have overall very similar 
effects on the liver miRNAome at three months (see significantly deregulated 
miRNAs for each treatment Table 6 and clustering Fig.1D), probably reflecting their 
common MOA. Interestingly, it was observed here that PB and BP could be 
distinguished at the miRNA level by the repression of miR-221 following BP 
treatment (Fig.2C). Several studies have reported that miR-221 is a liver oncogene, 
driving hepatocyte proliferation and suppressing apoptosis (Park et al., 2011; Pineau 
et al., 2010; Sharma et al., 2011). The repression of miR-221 after BP treatment 
could therefore contribute to the non-carcinogenicity of BP in these animals 
compared to PB.  
Regulation and adaptive functions of the miR-200a/200b/429 cluster and of miR-
34a  
The hepatic miRNAs most commonly affected by the tested chemicals were the 
members of the miR-200a/200b/429 cluster and miR-34a (Fig. 3A and 3B). MiR-
200b was not affected by treatment of male Fischer rats for seven days with 2-AAF or 
MP HCL (Fig.3C), indicating that it is only induced after longer treatments. For miR-
34a a significant induction could be observed in animals treated with 2-AAF or MP 
HCL from this early timepoint (Fig.3D), indicating that unlike for the miR-
200a/200b/429 cluster, its induction is an earlier and persistent effect.  
MiR-34a and miR-200b are known to be p53-regulated miRNAs (He et al., 2010; 
Kim et al., 2011). This is in agreement with the pronounced and persistent induction 
of this miRNA in rats treated with genotoxic 2-AAF. Only 2-AAF treatment resulted 
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in significant induction of a number of p53 regulated genes (e.g. bax 2.3 fold from 
control; cdkn1a 3.7 fold from control; ccng1 3.3-fold from control). In agreement 
with this observation, treatment of the rat hepatoma cell line Fao with the DNA-
damaging agent etoposide resulted in the induction of both miR-34a and miR-200b 
(Fig.4A). 
In contrast, the other three hepatocarcinogens that induce miR-34a are not thought to 
be DNA-damaging chemicals (Lijinski, 1984; NTP-TR-266; NTP-TR-304), hence 
their effect on the expression of this miRNA is probably occurring by alternative 
mechanisms. One such mechanism is the induction of oxidative stress, which has 
been suggested to be involved with the propagation of MP cytotoxicity (Craig et al., 
2006). Accordingly, MP HCL treatment resulted in the induction of three genes 
(akr7a3 4.3-fold; srxn1 1.9-fold; trib3 3.4-fold) which have been associated with 
glutathione depletion (Gao et al., 2010). Additionally, for both MON and Chl.Ac an 
enrichment of mRNAs involved in oxidation-reduction were observed, with this GO 
category being the only enriched one following treatment with the former chemical 
(Table 3). Hence, oxidative stress could be mechanism linking the induction of miR-
34a with these chemical treatments. Importantly, hydrogen peroxide treatment 
resulted in the induction of miR-34a, but not of miR-200b in Fao rat hepatoma cells, 
indicating that this miRNA can be induced by oxidative stress (Fig.4B). 
The miR-200 family inhibit epithelial to mesenchymal transition (EMT), a process 
which facilitates the acquisition of invasive and metastasic properties in numerous 
tissues, by promoting the expression of cdh1 (e-cadherin) through repression of the 
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zeb1/zeb2 transcription factors (reviewed in Dykxhoorn.,2010). However, cdh1 was 
not among the deregulated mRNAs in the livers of treated animals according to the 
transcriptomic data (data not shown). To confirm that this miRNA family associates 
with regulation of cdh1 in the rat liver we examined a cellular model whereby 
treatment of Fao rat hepatoma cells with tgf-β1 results in downregulation of cdh1 and 
morphological changes that are reminiscent of EMT (Caja et al.,2007). As reported 
(Caja et al.,2007), tgf-β1 treatment for 48 hours resulted in the downregulation of the 
expression of cdh1 in Fao cells (Fig.4C). We found that the downregulation of cdh1 
in tgf-β1 treated Fao cells is also associated with the downregulation of miR-200b 
(Fig.4C), suggesting that induction of these miRNAs are indeed involved in the 
regulation of the expression of cdh1 in rat hepatic cells.  
MiR-34a is an established negative regulator of the cell cycle (He et al., 2010). In 
agreement with this observation, transfection of anti-miR-34a into Fao cells resulted 
in an increased number of viable cells after three days of culture (Fig.4D). 
Transfection of miR-99a which was also affected by 2-AAF and MP HCl had no 
effect on cell growth (Fig.4D). The induction of hepatic miR-34a is therefore an early 
and persistent event that can act to prevent abnormal cell growth due to DNA-damage 
or oxidative stress. 
Using hepatic miRNA profiles to identify hepatocarcinogenic chemicals 
We finally examined whether hepatic miRNA biomarkers or signatures can facilitate 
the earlier identification of chemical hepatocarcinogens. An important limitation for 
such an analysis was the relatively small training set of compounds, which are 
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insufficient for the evaluation of sensitivity and specificity of any identified miRNA 
signatures. Nevertheless, such an analysis can be a preliminary indicator of whether 
miRNA data can be useful for deriving predictive models using data from a larger 
training set. For that purpose we tested the predictive abilities of the set of 10 
miRNAs which were significantly affected by two or more of the chemical treatments 
(Table 6). We utilized the prediction analysis of microarrays (PAM) software within 
the BRB-array tools developed by Dr. Richard Simon and the BRB-ArrayTools 
Development Team. PAM is a statistical technique that uses a gene signature 
(classifier) to assign class to samples using the nearest shrunken centroid (Tibshirani 
et al., 2002). Using this 10 miRNA signature the PAM algorithm could correctly 
classify all six hepatocarcinogenic treatments, as well as the non-hepatocarcinogen 
DETU (Fig.5A-5B). However this signature is probably too stringent, as it also 
classified BP as a hepatocarcinogen (Fig.5A-5B). In conclusion, this 10 miRNA 
signature was successful in correctly classifying the hepatocarcinogens, but gave 
ambiguous predictions for BP.  
 Discussion 
An important finding of this study was that all the tested carcinogens affected the 
expression of hepatic miRNAs at three months. In this context, it is important to note 
that the only two studies in which hepatocarcinogenic chemicals were reported not to 
affect hepatic miRNAs liver had examined livers following acute treatments (Moffat 
et al., 2007;  Yauk et al., 2010), in contrast to acute treatment with the hepatotoxins 
acetaminophen and carbon tetrachloride, which deregulated miRNAs within twenty 
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four hours (Fukushima et al., 2007). Additionally, it has recently been reported that 
treatment with the genotoxic hepatocarcinogen ENU has minimal effects on liver -
miRNAs after one or three days, but has much more prominent effects after 14 and 28 
days (Li et al., 2010). Together, these observations suggest that liver miRNAs appear 
to be initially refractory to acute hepatocarcinogenic treatments, although the reason 
behind this discrepancy is currently unknown. However, the data collected here make 
it clear that sub-chronic and chronic chemical treatments eventually induce prominent 
effects on the liver miRNAome that are discernable well before the appearance of 
hepatic tumors.   
While some effects of the treatments on the liver miRNAome were chemical specific, 
a small set of miRNAs were commonly affected by the diverse carcinogenic 
treatments which were examined here. It is noteworthy that this set did not include 
miRNAs which have been previously strongly associated with HCC- such as miR-
122, miR-21, and miR-199a-3p (Hou et al., 2011; Pineau et al., 2010). These 
miRNAs may not be important in chemically-induced hepatocarcinogenesis or 
alternatively they may not be deregulated until the later stages of the disease.  
The most commonly chemical-affected hepatic miRNAs at three months were 
members of the miR-200a/200b/429 cluster and miR-34a (Fig.3A-3B). In recent 
years numerous studies have reported that the miR-200 family act as a positive 
regulator of the expression of cdh1, an important cell-to-cell adhesion molecule 
(reviewed in Dykxhoorn ,2010). Downregulation of cdh1 is a key event implicated in 
epithelial-mesenchymal transition (EMT), a developmental process involved in the 
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acquisition of invasive faculties in liver cancer (Ding et al.,2010; Kim et al., 2011). 
We showed here that the miR-200a/200b/429 cluster is downregulated during tgf-β1 
induced repression of cdh1 in Fao rat hepatoma cells. The induction of the miR-
200a/200b/429 cluster could be an adaptive response protecting the epithelial state of 
hepatocytes by sustaining high levels of cdh1 expression. 
MiR-34a has been reported to be upregulated in HCC (Pineau et al., 2010), as well as 
in response to treatment with hepatocarcinogens (Li et al., 2011; Malik et al., 2011; 
Pogribny et al., 2007; Shah et al., 2007). Here it was unaffected by the two non-
hepatocarcinogenic treatments at three months, while it was significantly induced by 
all four non-nuclear receptor activating hepatocarcinogens (Fig.3B). This miRNA has 
widespread effects on the proteome of hepatic cells, resulting in a cell cycle block 
(Cheng et al.,2010), and has also been reported to be involved in terminating liver 
regeneration after hepatectomy (Chen et al.,2011). The in vivo and in vitro findings in 
this study suggest that this miRNA is involved in the hepatic response to DNA-
damage and oxidative stress. Paradoxically, we found here that this miRNA was 
persistently induced by the two chemical treatments that resulted in increased cell 
cycle at three months, MP HCl and 2-AAF (Table 2-4). One possible explanation of 
this phenomenon is that the proliferating liver cells are a hepatic sub-population in 
which this miRNA is not induced. Alternatively, the proliferative and anti-apoptotic 
effects of these carcinogens may overcome the cell cycle block that is associated with 
miR-34a activity. Interestingly, the expression of miR-34a is progressively increased 
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in HCC (Pineau et al., 2010), indicating that hepatic cancer cells can bypass the 
tumor-suppressive properties of this miRNA.  
This study therefore suggests that liver miRNAs have fundamental roles in directing 
adaptive responses during the early stages of chemical hepatocarcinogenesis (Fig. 6). 
This does not exclude the possibility that other deregulated miRNAs that were 
identified here may have adverse functions, for example miR-99a which is commonly 
repressed in HCC (Hou et al., 2010).  
Omics technologies are being pursued as potential methodology that can complement 
or replace the 2-year rodent bioassay (Blomme et al., 2009; Ellinger-Ziegelbauer et 
al., 2008). It has been reported that the mRNA profiles of livers reflect the MOA of 
the chemicals with which they are treated (Ellinger-Ziegelbauer et al., 2008). An 
important question for this study was whether examination of hepatic miRNA profiles 
could offer mechanistic information about the tested chemicals. The observations 
collected here suggest that a similar link exists between chemical mechanisms and 
hepatic miRNA profiles. Firstly, the tested nuclear receptor activators and non-
nuclear receptor activators had clearly distinct miRNA profiles at three months of 
treatment (Correlated induction of miR-200a/200b/429 and miR-96/182 cluster vs. 
induction of miR-34a). Second, hierarchical clustering analysis demonstrated the 
similar miRNA profiles of two structurally diverse PB-type compounds (PB and BP) 
and of the chemicals which had the strongest effect on the cell cycle and apoptosis (2-
AAF and MP HCL). Third, expression of miRNAs was linked to carcinogenic 
mechanisms e.g. miR-34a with genotoxicity and oxidative stress. Fourth, 
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hepatocarcinogenic PB treatment could be discriminated from non-
hepatocarcinogenic BP treatment from differential effects on miR-221, a miRNA 
which is strongly linked with liver cancer development. 
Given the observations discussed above, a reasonable hypothesis would be that 
miRNA biomarkers or signatures can be identified that will facilitate the safety 
evaluation of chemicals, with due respect to the caveat that only a small number of 
chemicals were tested here. However, it is important to note that this study supports, 
as a proof-of-principle, that miRNA expression contains predictive information. Of 
the hepatic miRNAs found to be deregulated in this study miR-34a showed the 
greatest potential to be a useful biomarker for those chemical hepatocarcinogens 
which act through the induction of DNA-damage or oxidative stress. We also used the 
PAM software to evaluate the predictive powers of hepatic miRNA signatures 
(Fig.5). This analysis indicates that hepatic miRNA profiles could classify the tested 
hepatocarcinogens and correctly classify DETU as a non-hepatocarcinogen. This 
could be especially useful for non-DNA reactive hepatocarcinogens such as MON 
and Chl.Ac which are difficult to identify based on their effects on liver pathology 
and clinical chemistry.  In this context, the recent reports that circulating miRNAs 
could offer biomarkers of tissue injury and hepatocarcinogenesis (Laterza et al., 2009 
and Sukata et al., 2011) are important.  
The DNA-damaging and mutagenic consequences of exposure to genotoxic 
hepatocarcinogens are well characterized, but the molecular events associated with 
non-genotoxic chemicals are not so well understood. To the best of our knowledge 
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this was the first study that has investigated in depth the effects of treatments with 
diverse genotoxic and non-genotoxic chemical hepatocarcinogens on the liver 
miRNAome. The data generated here support the hypothesis that hepatic miRNA 
profiles can facilitate an improved mechanistic understanding and the earlier 
prediction of chemical hepatocarcinogens, including non-genotoxic chemicals. 
Currently such predictions are very difficult.  
 
Funding: 
This work was supported by funding from the Biotechnology and Biological Sciences 
Research Council (BBSRC, UK) in association with Syngenta. 
Page 22 of 43Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
23 
 
References 
Bala, S., Marcos, M., and Szabo, G. (2009) Emerging role of microRNAs in liver 
diseases. World Journal of Gastroenterology 15 (45), 5633-5640. 
Blomme, E.A.G., Yang, Y., and Waring, J.F. (2009) Use of toxicogenomics to 
understand mechanisms of drug-induced hepatotoxicity during drug discovery and 
development. Toxicology Letters 186 (1), 22-31. 
Boobis, A.R., Cohen, S.M., Doerrer, N.G., Galloway, S.M., Haley, P.J., Hard, G.C., 
 Hess, F.G., Macdonald, J.S., Thibault, S., Wolf, D.C., and Wright J (2009) A Data-
Based Assessment of Alternative Strategies for Identification of Potential Human 
Cancer Hazards. Toxicologic Pathology; 37 (6), 714-732. 
Butler, W.H. (1978) Long-term effects of phenobarbitone-Na on male Fischer rats. 
British Journal Cancer. 37(3):418-23. 
Caja, L., Ortiz, C., Bertran, E., Murillo, M.M., Miró-Obradors, M.J., Palacios, E., and 
Fabregat, I. (2007) Differential intracellular signalling induced by TGF-beta in rat 
adult hepatocytes and hepatoma cells: implications in liver carcinogenesis. Cell 
Signalling 4,683-94. 
Chen, H., Sun, Y., Dong, R., Yang, S., Pan, C., Xiang, D., Miao, M., and Jiao, B. 
(2011) Mir-34a Is Upregulated during Liver Regeneration in Rats and Is Associated 
with the Suppression of Hepatocyte Proliferation. PLoS One 6(5):e20238 
Cheng, J., Zhou, L., Xie, Q.F., Xie, H.Y., Wei, X.Y., Gao, F.,  Xing, C.Y., Xu, X., Li, 
L.J., and Zheng, S.S. (2010) The impact of miR-34a on protein output in 
hepatocellular carcinoma HepG2 cells. Proteomics 10(8):1557-72. 
Chhabra, R.S. NTP (2000) technical report on the toxicity studies of benzophenone 
(CAS No. 119-61-9). Administered in feed to F344/N rats and B6C3F mice. Toxicity 
Report Series 61:1-53, A1-13. 
Page 23 of 43 Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
24 
 
Craig, A,, Sidaway, J., Holmes, E., Orton, T., Jackson, D., Rowlinson, R., Nickson, J., 
Tonge, R., Wilson, I., and Nicholson, J. (2006) Systems toxicology: integrated genomic, 
proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the 
rat. Journal of Proteome Research 5(7):1586-601. 
Ding, W., You, H., Dang, H., LeBlanc, F., Galicia, V., Lu, S.C., Stiles, B., and 
Rountree, C.B. (2010) Epithelial-to-mesenchymal transition of murine liver tumor 
cells promotes invasion. Hepatology 52 (3):945-53. 
 
Dykxhoorn, D.M. (2010) MicroRNAs and metastasis: little RNAs go a long way. 
Cancer Research 15;70(16):6401-6.  
Ellinger-Ziegelbauer, H., Grnuender, H., Brandenburg, A. and Ahr, H. J. (2008) 
Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics 
analysis of short-term in vivo studies. Mutation Research-Fundamental and 
Molecular Mechanisms of Mutagenesis, 637 (1-2), 23-39. 
Fukushima, T., Hamada, Y., Yamada, H. and Hori, I. (2007). Changes of micro-RNA 
expression in rat liver treated by acetoaminophen or carbon tetrachloride: regulating 
role of micro-RNA for RNA expression.  J Toxicol. Sci. 32 (4), 401-9. 
Gao, W., Mizukawa, Y., Nakatsu, N., Minowa, Y., Yamada, H., Ohno, Y., and 
 Urushidani, T. (2010) Mechanism-based biomarker gene sets for glutathione 
depletion-related hepatotoxicity in rats. Toxicoly Applied Pharmacology 
15;247(3):211-21.  
Hardisty, J.F. and Brix, A.E. (2005) Comparative hepatic toxicity: Prechronic/chronic 
liver toxicity in rodents. Toxicological Pathology  33 (1), 35-40. 
Hermeking, H. (2010) The miR-34 family in cancer and apoptosis. Cell Death 
Differentiation 17(2):193-9. 
 
Page 24 of 43Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
25 
 
Hernandez, L.G., van Steeg, H., Luijten, M. and van Benthem, J. (2009) Mechanisms 
of non-genotoxic carcinogens and importance of a weight of evidence approach. 
Mutation Research-Reviews in Mutation Research 682 (2-3), 94-109. 
Hou, J., Lin, L., Zhou, W., Wang, Z., Ding, G., Dong, Q., Qin, L., Wu, X., Zheng, 
Y., Yang, Y., Tian, W., Zhang, Q., Wang, C., Zhang, Q., Zhuang, S.M., Zheng, 
L., Liang, A., Tao, W., and Cao, X. (2011) Identification of miRNomes in human 
liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for 
hepatocellular carcinoma. Cancer Cell 19(2):232-43. 
Irigaray, P. and Belpomme, D. (2010) Basic properties and molecular mechanisms of 
exogenous chemical carcinogens. Carcinogenesis 31 (2), 135-148. 
Kim, T., Veronese, A., Pichiorri, F., Lee, T.J., Jeon, Y.J., Volinia, S., Pineau, P., 
Marchio, A., Palatini, J., Suh, S.S., Alder, H., Liu, C.G., Dejean, A., and Croce, C.M. 
(2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting 
ZEB1 and ZEB2. Journal of Experimental Medicine 208(5):875-83. 
Kodama, S. and Negishi, M. (2006) Phenobarbital confers its diverse effects by 
activating the orphan nuclear receptor car. Drug Metabolism Reviews 38(1-2):75-87.  
Lake, B.G. (2009) Species differences in the hepatic effects of inducers of CYP2B 
and CYP4A subfamily forms: relationship to rodent liver tumour formation. 
Xenobiotica  39(8):582-96. 
 
Lapinskas, P.J., Brown, S., Leesnitzer, L.M., Blanchard, S., Swanson, C., Cattley, 
R.C., and Corton, J.C. (2005) Role of PPAR alpha in mediating the effects of 
phthalates and metabolites in the liver. Toxicology  207 (1), 149-163. 
Laterza, O.F., Lim, L., Garrett-Engele, P.W., Vlasakova, K., Muniappa, N., Tanaka, 
W.K., Johnson, J.M., Sina, J.F., Fare, T.L., Sistare, F.D. and Glaab, W.E. (2009).  
Page 25 of 43 Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
26 
 
Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem. 
55 (11), 1977-83.  
Li, Z.G., Branham, W.S., Dial, S.L., Wang, Y.X., Guo, L., Shi, L.M., and Chen, T. 
(2010) Genomic analysis of microRNA time-course expression in liver of mice 
treated with genotoxic carcinogen N-ethyl-N-nitrosourea. Bmc Genomics 11. 
Lijinsky, W. (1984) Chronic Toxicity Tests of Pyrilamine Maleate and Methapyrilene 
Hydrochloride in F344 Rats. Food and Chemical Toxicology 22 (1), 27-30. 
Moffat, I.D., Boutros, P.C., Celius, T., Linden, J., Pohjanvirta, R. and Okey, A.B. 
(2007) MicroRNAs in adult rodent liver are refractory to dioxin treatment. 
Toxicological Sciences 99, 470-487. 
Neumann, H.G., Bitsch, A., and Klöhn, P.C. (1997) The dual role of 2-
acetylaminofluorene in hepatocarcinogenesis: specific targets for initiation and 
promotion. Mutation Research  376(1-2):169-76. 
NTP TR-149. (1979) Bioassay of N,N'-Diethylthiourea for Possible Carcinogenicity 
(CAS No. 105-55-5)  
NTP TR-217 (1982) Carcinogenesis Bioassay of Di(2-ethylhexyl)phthalate (CAS No. 
117-81-7) in F344 Rats and B6C3F1 Mice (Feed Studies). CAS No. 117-81-7. 
NTP TR-266. (1988) Toxicology and Carcinogenesis Studies of Monuron (CAS No. 
150-68-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).  
NTP TR-304. (1987) Toxicology and Carcinogenesis Studies of Chlorendic Acid 
(CAS No. 115-28-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).  
NTP TR-533 (2006) Toxicology and Carcinogenesis Studies of Benzophenone (CAS 
No. 119-61-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). CAS No. 119-61-9. 
Ogiso, T., Tatematsu, M., Tamano, S., Tsuda, H. and Ito, N. (1985) Comparative 
Effects of Carcinogens on the Induction of Placental Glutathione-S-Transferase-
Page 26 of 43Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
27 
 
Positive Liver Nodules in a Short-Term Assay and of Hepatocellular Carcinomas in a 
Long-Term Assay. Toxicological Pathology 13 (4), 257-265. 
Park, J.K., Kogure, T., Nuovo, G.J., Jiang, J., He, L., Kim, J.H., Phelps, M.A., 
Papenfuss, T.L., Croce, C.M., Patel, T., and Schmittgen, T.D. (2011) miR-221 
Silencing Blocks Hepatocellular Carcinoma and Promotes Survival. Cancer Research 
71 (24) 7608-16. 
Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., 
 Mazzaferro, V., Lowe, S.W., Croce, C.M., and Dejean A. (2010) miR-221 
overexpression contributes to liver tumorigenesis. PNAS 107 (1), 264-269. 
Pogribny, I.R., Muskhelishvili, L., Tryndyak, V.P. and Beland, F.A. (2009) The 
tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of 
the p53 signaling pathway and the balance between apoptosis and cell proliferation. 
Toxicology and Applied Pharmacology  235 (3), 305-311. 
Shah, Y.A., Morimura, K., Yang, Q., Tanabe, T., Takagi, M. and Gonzalez, F.J. 
(2007) Peroxisome proliferator-activated receptor alpha regulates a microRNA-
mediated signaling cascade responsible for hepatocellular proliferation. Molecular 
and Cellular Biology  27 (12), 4238-4247. 
Sharma, A.D., Narain, N., Händel, E.M., Iken, M., Singhal, N., Cathomen, T., Manns, 
M.P., Schöler, H.R., Ott, M., and Cantz, T. (2011) MicroRNA-221 regulates FAS-
induced fulminant liver failure. Hepatology. 53(5):1651-61. 
Sukata, T., Sumida, K., Kushida, M., Ogata, K., Miyata, K., Yabushita, S., and 
Uwagawa, S. (2011). Toxicol. Lett., 200 (1-2), 46-52.  
Tibshirani, R., Hastie, T., Narasimhan, B. and Chu, G. (2002) Diagnosis of multiple 
cancer types by shrunken centroids of gene expression. PNAS, 99 (10), 6567-6572. 
Page 27 of 43 Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
28 
 
Waterman, C.L., Currie, R.A., Cottrell, L.A., Dow, J., Wright, J., Waterfield, C.J.,   
and Griffin, J.L. (2010) An integrated functional genomic study of acute 
phenobarbital exposure in the rat. BMC Genomics 11, 9. 
Yauk, C.L., Jackson, K., Malowany, M.W. and Williams, A. (2010). Lack of change 
in microRNA expression in adult mouse liver following treatment with 
benzo(a)pyrene despite robust mRNA transcriptional response. Mutation Research-
Genetic Toxicology and Environmental Mutagenesis doi:10.1016 
 
Page 28 of 43Toxicological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 at Im
perial College London Library on June 6, 2012
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
29 
 
Tables 
Table 1: Summary of chemical treatments 
Compound Dose 
(ppm) 
Number of 
neoplasias/carcinomas in 
2-year bioassay in male 
Fischer rat 
Reference 
Diethythiourea (DETU) 250 0/50 (0%) (NTP TR-149, 1979) 
Benzophenone (BP) 1250 0/50 (0%) (NTP TR-533, 2006) 
Monuron (MON) 1500 9/50 (18%) (NTP TR-266, 1988) 
Diethylhexylphthalate 
(DEHP) 
12000 12/49 (24%) (NTP TR-217, 1982) 
Phenobarbital 
(PB) 
1000 11/33 (33%) (Butler, 1978) 
Chlorendic Acid 
(Chl.Ac) 
1250 23/50 (46%) (NTP TR-304, 1987) 
Methapyrilene 
hydrochloride           
(MP HCL) 
250 18/20 (90%) (Lijinsky, 1984) 
2-Acetylaminofluorene 
(2-AAF) 
40 23/23 (100%) (Ogiso et al., 1985) 
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Table 2: Effect of chemical treatments on liver pathology and plasma clinical 
parameters 
 CON DETU BP MON DEHP PB Chl. 
Ac 
MP 
HCL 
2-AAF 
Terminal 
Bodyweight 
(g) 
349.8±2
1.3 
350±2
0.8 
353.8±3
3.2 
308.8±2
6.2 
313.4±2
2.1 
356.8
±9 
319±1
8.7 
346.6
±5 
334.6±
4.3 
Liver Weight 
(g) 
12.4±1.
3 
12.5±
1.6 
15.5±2.
1** 
11.7±1.
2 
18.7±2.
1** 
15.8±
0.8 
10.6±
0.5 
12.5±
0.5 
12.1±0
.8 
Adjusted 
liver weight 
11.6 11.7 14.7* 13.1* 19.9* 14.7* 11.5 11.9 12.2 
Hypertrophy 0/5 0/5 5/5 0/4 5/5 4/4 0/4 0/5 0/5 
Vacuolation 0/5 0/5 4/5 4/4 0/5 4/4 0/4 0/5 0/5 
Necrosis/apo
ptosis 
0/5 0/5 0/5 0/4 0/5 0/4 0/4 4/5 0/5 
Biliary 
hyperplasia 
+/- 
inflammation 
0/5 0/5 0/5 0/4 0/5 0/4 0/4 5/5 5/5 
Alanine 
amino-
transferase 
(IU/L) 
71.4 82.6** 83.0** 85.2** 61.4* 85.3*
* 
81.5* 96.8*
* 
80.8** 
Aspartate 
Amino-
transferase 
(IU/L) 
68 ± 9.2 70.2 ± 
8.1 
75.4 ± 
14.2 
66.6 ± 
2.1 
53.8 ± 
3.6** 
69.5  
± 4.5 
70.3  
± 4.2 
88.8 ± 
10.3*
* 
67.8 ± 
3.1 
Glutamate 
dehydrogena
se (IU/L) 
4.64 ± 
1.09 
7.85 ± 
2.32 
4.48 ± 
0.45 
4.78 ± 
1.21 
4.32  ± 
0.59 
5.93 ± 
0.42 
7.70 ± 
1.57* 
16.72 
± 
5.62* 
3.52 ± 
0.33 
Liver weights were analysed by analysis of covariance on final bodyweight. For the 
other measurements ANOVA was used. CON is control group, for the other 
treatments see abbreviations in Table 1. Mean values and standard deviations are 
shown, n=3-5 animals per group. * p<0.05 ** p<0.01 
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Table 3: Effects of chemical treatments on mRNA profiles 
Treatment Number of 
significantly 
deregulated probes * 
Enriched 
GO groups# 
DETU 100 None 
BP 186 Response to stimulus 
MON 127 Oxidation reduction 
 
DEHP 
771 Numerous including  oxidation 
reduction, fatty-acid metabolic 
process, carbohydrate metabolic 
process 
 
PB 
280 Glutathione transferase activity, 
monoxygenase activity, 
oxidoreductase activity, catalytic 
activity 
Chl.Ac 320 Carboxylic acid, lipid metabolic 
process, oxidation reduction 
MP HCL 188 Cell cycle; Mitosis 
2-AAF 271 Cell cycle and programmed cell 
death 
 
* Deregulated probes were identified as those with a p value <0.05 and more than 1.5 fold-
change by a T-test between treated and control groups. For treatment abbreviations, see Table 
1.  #Enriched GO groups were those with p<0.01. 
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Table 4: Cell cycle mRNAs affected by 2-AAF and MP HCL 
Gene name Fold change in 2-
AAF treated  
Fold change in MP 
HCL treated  
Significant change by other 
treatments 
ccnd1 2.9 1.9 Chl.Ac (2.1) 
cdca3 30.3 41.6 None 
kif11 2.6 2.9 Chl.Ac (2.3) 
ccnb2 5.2 5.7 None 
tubb5 1.5 1.9 None 
cdkn3 16.7 18.7 Chl.Ac (8.1) 
cdc2 6.8 7.0 DETU (3.9); BP (2.9); Chl.Ac (3.9) 
ccnb1 4.7 5.9 DEHP (1.9); DETU (3.4); BP (2.1); 
PB (2.4); Chl.Ac (3.5) 
cdkn2c 2.1 1.9 DEHP (1.6) 
nusap1 2.8 3.7 BP (2.0); DETU (1.7) 
stmn1 2.2 3.2 DETU (1.5);  PB (2.3); BP (1.5); 
Chl.Ac (2.3) 
ube2c 2.3 3.7 DETU (1.7) 
mdm2 2.3 -1.9 None 
pttg1 n.s. 5.1 None 
smc2 n.s 2.4 None 
uhmk1 n.s. -2.0 None 
txnl4b n.s. 1.5 BP (1.6); MON (1.5) 
ncapd2 n.s. 2.7 None 
nampt -2.4 n.s. PB (-1.8); Chl.Ac (-2.4) 
steap3 -1.7 n.s. BP (-1.7) 
pkd1 -1.6 n.s. None 
anapc11 -1.6 n.s. DEHP (-1.7); BP (-1.5); 
nek6 1.6 n.s. None 
rprm 1.9 n.s. PB (-2.0) 
wee1 1.9 n.s. Chl.Ac (2.2) 
rhob 2.0 n.s. None 
rgs2 2.1 n.s. None 
tp53inp1 2.1 n.s. Chl.Ac (2.5) 
ccng1 3.3 n.s. None 
cdkn1a 3.7 n.s. None 
phlda3 4.1 n.s. DEHP (-3.1) 
Significantly deregulated probes were identified as those with a p value <0.05 and 
more than 1.5 fold-change by a T-test between treated and control groups at 90 days. 
Values shown are the mean fold change between control and chemical-treated 
animals as determined by microarray analysis of mRNAs which were affected by MP 
HCL and 2-AAF treatment and are involved in the “cell cycle” GO category. 
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Table 5: Genes involved in programmed cell death which are affected by 2-AAF 
treatment  
Gene ID 2-AAF (Fold change compared 
to control) 
Other treatments (Fold change 
compared to control)
 
bax 2.3 None 
fas 4.2 None 
cdkn1a 3.7 None 
tp53inp1 2.1 Chl.Ac (2.5) 
cd44 2.0 None 
zmat3 2.1 None 
sox4 2.4 None 
tubb2c 2.5 None 
cck -1.6 None 
hmox1 -1.6 none 
aldh1a3 2.1 None 
phlda3 4.1 DEHP (-3.1) 
c6 -3.5 DEHP (-4.4); MON (-2.9); 
Chl.Ac (-2.9) 
nupr1 -2.3 DEHP (-2.8); Chl.Ac (3.9) 
aen 1.8 DEHP (-1.7) 
steap3 -1.7 BP (-1.7) 
ripk1 -1.6 MP HCL (-2.4) 
cdkn2c 2.1 MP HCL (1.9); DEHP (1.6) 
aldh1a1 3.4 PB (5.8); DEHP (5.5); BP (4.4); 
MON (3.3)   
top2a 4.7 MP HCL (5.5); DETU (2.2); 
Chl.Ac (2.9) 
 
Significantly deregulated probes were identified as those with a p value <0.05 and 
more than 1.5 fold-change by a T-test between treated and control groups at 90 days. 
Values shown are the mean fold change between control and chemical-treated 
animals as determined by microarray analysis of mRNAs which were affected by 2-
AAF treatment and are involved in the “programmed cell death” GO category. 
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Table 6: Differentially expressed microRNAs after 90 days of chemical treatment 
 
microRNA 
 
Corrected 
p.value 
 
DETU 
 
BP 
 
PB 
 
DEHP 
 
MON 
 
Chl. Ac 
 
MP HCL 
 
2-AAF 
miR-34a >0.01 -1.1 -1.3 1 -1.2 3.9 2.3 1.7 27.9 
miR-96 >0.01 1.3 2.0 3.6 1.6 1.6 -1.5 1.0 -1.3 
miR-221 >0.01 -1.5 -1.8 -1.1 3 -1.2 1.5 1.0 -1.1 
miR-200a >0.01 -1.2 2.0 3.7 1.7 1.1 2.0 1.7 2.0 
miR-107 >0.01 -1.1 1.1 -1.1 2.0 1.0 1.1 -1.2 -1.3 
miR-200b >0.01 -1.0 2.5 4.5 2.0 1.2 2.3 1.6 2.0 
miR-429 >0.01 -1.1 2.4 3.8 1.9 1.2 2.3 1.8 2.7 
miR-182 >0.01 2.4 4.3 6.3 3.1 3.3 1.1 1.3 1.4 
miR-375 >0.01 -2.0 -2.3 -2.0 1.8 2.2 1.7 -2.1 -1.5 
miR-193 >0.01 -1.3 -1.1 1.2 -1.7 -2.4 -4.9 -1.9 -1.3 
miR-17 >0.01 -1.1 1.1 -1.1 1.1 1.0 -1.6 -1.2 -1.2 
miR-497 >0.01 1.0 -1.1 -1.1 -1.2 -1.3 -1.7 -1.3 -1 
miR-203 0.01 -1.2 -1.1 -1.4 -1.4 -1.2 -2 -1.2 -1.6 
miR-31 0.01 1.1 1.1 -1 1.3 -1.0 1.3 -1.4 -1.5 
miR-29a 0.01 -1.1 -1 1.1 1.3 1.0 -1.2 -1.2 -1.2 
miR-29c 0.01 -1.1 1.0 1.2 1.3 -1.0 -1.3 -1.2 -1.2 
miR-99a 0.02 -1.0 -1.3 -1.3 -1.3 -1.5 -1.3 -1.5 -1.6 
miR-20a 0.03 -1.0 1.0 -1.1 1.1 -1.0 -1.6 -1.2 -1.3 
miR-139-5p 0.03 1.3 -1.1 1.1 1.3 1.3 3.2 1.3 -1.3 
miR-28 0.04 1.1 1 1.1 -1.1 1.0 1.4 1.0 -1.3 
miR-505 0.05 -1.1 1.1 1.5 1.5 1.1 2.8 1.2 -1.6 
Differentially regulated miRNAs were identified using one-way ANOVA with 
Bonferonni-Holm multiple testing correction and p<0.05. For treatment 
abbreviations, see Table 1. Values shown are average absolute fold change from 
control in that treatment. Underlined are miRNAs with significantly altered 
expression in livers of treated animals compared to control animals (Tukey HSD post 
test p<0.05). 
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Figure legends 
Figure 1 Verification of miRNA microarray data and clustering analysis (A) 
Each box-plot on the x-axis represents a microarray sample. The lower end of the box 
is the 25th percentile, while the highest end is the 75th percentile. On the Y-axis is 
plotted the normalised log2 intensity from the microarrays. The black line in the 
middle of each box-plot is the median value for that sample. The open circle signifies 
the log2 value of the miRNA with the highest intensity in each sample. End of the 
whiskers contain 1.5 interquartile range; (B) Comparison of the expression of 
detected miRNAs for two sets of control and PB technical replicates for which RNA 
was extracted twice and analysed independently, n=3 per group; (C) Correlation 
between fold changes for selected miRNAs calculated by microarrays and qPCR, 
Pearson’s correlation is shown; (D) Hierarchical analysis of control and chemical-
treated animals based on the expression of 21 differentially expressed miRNAs. The 
tree was constructed using correlation uncentred and average linkage. The expression 
of miRNAs was median centred and normalised in cluster 3.0. Red colour indicates 
upregulated miRNAs, the green colour downregulated, and the black colour no 
change. 
 
Figure 2 Hepatic miRNA profiles associated with tested nuclear receptor 
activators. (A) Comparison of the expression of miR-200b and miR-96 in livers of 
animals treated with nuclear receptor activating compounds (B) Comparison of the 
expression of miR-200b and miR-96 in livers of animals treated with non-nuclear 
receptor activating compounds (right); (C) Mean fold change in expression of miR-
221 compared to control after three months of PB and BP treatment, error bars 
indicate s.d., N=3-5 animals  
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Figure 3 Effect of chemical treatments on the expression of miR-200a/200b/429 
cluster and miR-34a (A) Mean fold change in expression of members of the miR-
200a/200b/429 clusters compared to control after three months for each treatment 
group; (B) Mean fold change in expression of miR-34a compared to control after 
three months for each treatment group; (C) Effect of 2-AAF and MP HCL treatment 
on the expression of miR-200b after seven days; N=3 animals per group ;  (D) Effect 
of 2-AAF and MP HCL treatment on the expression of miR-34a; N=3 animals per 
group. Mean values ± s.d. for (A) and (B) and s.e.m. for (C) and (D). * p<0.05 ** 
p<0.01 from control by one way ANOVA with Benjamini Hochberg multiple testing 
correction and Tukey HSD post test. 
 
Figure 4 Regulation and functional effects associated with induction of miR-
200a/200b/429 and of miR-34a (A) Effect of etoposide (50µM for 48 hours) on the 
expression of miR-34a and miR-200b in the Fao rat hepatoma cell lines; (B) Effect of 
hydrogen peroxide treatment (500µM for 24 hours) on the expression of miR-34a and 
miR-200b in the Fao rat hepatoma cell lines; (C) Expression of cdh1 and miR-200b in 
Fao cells treated with 2ng/ml TGF-beta1 for 48 hours. Representative result of two 
independent experiments is shown; (D) Effect of transfection with 50nm of anti-miR-
34a, miR-96, miR-99a, and negative control oligo on the number of viable cells after 
three days. Mean values ± s.e.m are shown, N=3, * p<0.05 **p<0.01. 
 
Figure 5 PAM prediction of hepatocarcinogenic and non-hepatocarcinogenic 
chemical treatments based on signature of 10 miRNAs (A) Cross-validated 
probabilities of a sample classified as undergoing a carcinogenic (indicated by a red 
circle) or carcinogenic (indicated by a green circle) by the PAM software using as the 
PAM classifier the miRNA signature of 10 miRNAs which were significantly 
differentially regulated in animals exposed to two or more treatments; (B) List of 
number of examined liver samples that were correctly or incorrectly classified. 
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Figure 6 proposed model of the adaptive functions of hepatic miR-34a and miR-
200a/200b/429 during the early stages of chemical hepatocarcinogenesis 
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Figure 1.  Verification of miRNA microarray data and clustering analysis (A) Each box-plot on the x-axis 
represents a microarray sample. The lower end of the box is the 25th percentile, while the highest end is the 
75th percentile. On the Y-axis is plotted the normalised log2 intensity from the microarrays. The black line in 
the middle of each box-plot is the median value for that sample. The open circle signifies the log2 value of 
the miRNA with the highest intensity in each sample. End of the whiskers contain 1.5 interquartile range; 
(B) Comparison of the expression of detected miRNAs for two sets of control and PB technical replicates for 
which RNA was extracted twice and analysed independently, n=3 per group; (C) Correlation between fold 
changes for selected miRNAs calculated by microarrays and qPCR, Pearson’s correlation is shown; (D) 
Hierarchical analysis of control and chemical-treated animals based on the expression of 21 differentially 
expressed miRNAs. The tree was constructed using correlation uncentred and average linkage. The 
expression of miRNAs was median centred and normalised in cluster 3.0. Red colour indicates upregulated 
miRNAs, the green colour downregulated, and the black colour no change.  
177x133mm (300 x 300 DPI)  
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Figure 2. Hepatic miRNA profiles associated with tested nuclear receptor activators. (A) Comparison of the 
expression of miR-200b and miR-96 in livers of animals treated with nuclear receptor activating compounds 
(B) Comparison of the expression of miR-200b and miR-96 in livers of animals treated with non-nuclear 
receptor activating compounds (right); (C) Mean fold change in expression of miR-221 compared to control 
after three months of PB and BP treatment, error bars indicate s.d., N=3-5 animals  
254x190mm (300 x 300 DPI)  
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Figure 3. Effect of chemical treatments on the expression of miR-200a/200b/429 cluster and miR-34a (A) 
Mean fold change in expression of members of the miR-200a/200b/429 clusters compared to control after 
three months for each treatment group; (B) Mean fold change in expression of miR-34a compared to control 
after three months for each treatment group; (C) Effect of 2-AAF and MP HCL treatment on the expression 
of miR-200b after seven days; N=3 animals per group ;  (D) Effect of 2-AAF and MP HCL treatment on the 
expression of miR-34a; N=3 animals per group. Mean values ± s.d. for (A) and (B) and s.e.m. for (C) and 
(D). * p<0.05 ** p<0.01 from control by one way ANOVA with Benjamini Hochberg multiple testing 
correction and Tukey HSD post test.  
254x190mm (300 x 300 DPI)  
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Figure 4. Regulation and functional effects associated with induction of miR-200a/200b/429 and of miR-34a 
(A) Effect of etoposide (50µM for 48 hours) on the expression of miR-34a and miR-200b in the Fao rat 
hepatoma cell lines; (B) Effect of hydrogen peroxide treatment (500µM for 24 hours) on the expression of 
miR-34a and miR-200b in the Fao rat hepatoma cell lines; (C) Expression of cdh1 and miR-200b in Fao cells 
treated with 2ng/ml TGF-beta1 for 48 hours. Representative result of two independent experiments is 
shown; (D) Effect of transfection with 50nm of anti-miR-34a, miR-96, miR-99a, and negative control oligo 
on the number of viable cells after three days. Mean values ± s.e.m are shown, N=3, * p<0.05 **p<0.01.  
254x190mm (300 x 300 DPI)  
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Figure 5. PAM prediction of hepatocarcinogenic and non-hepatocarcinogenic chemical treatments based on 
signature of 10 miRNAs (A) Cross-validated probabilities of a sample classified as undergoing a carcinogenic 
(indicated by a red circle) or carcinogenic (indicated by a green circle) by the PAM software using as the PAM 
classifier the miRNA signature of 10 miRNAs which were significantly differentially regulated in animals 
exposed to two or more treatments; (B) List of number of examined liver samples that were correctly or 
incorrectly classified.  
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Figure 6. Proposed model of the adaptive functions of hepatic miR-34a and miR-200a/200b/429 during the 
early stages of chemical hepatocarcinogenesis  
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